Results of from the fantastically named OCTAPUS AI study showed artificial intelligence could accurately and efficiently spot patients who are likely to suffer from recurrence following treatment for non-small cell lung cancer (NSCLC).
NSCLC can be treated if it is caught early and compared to small cell lung cancer, and five-year survival rates are almost triple
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?